INTERNATIONAL AGENCY FOR THE PREVENTION OF BLINDNESS
Financial health, per its FY2024 accounts
The accounts state that unrestricted free reserves stood at £909,644, representing 2.7 months of budgeted operating expenditure, which is slightly below the charity's own policy target of three months. Despite this slight shortfall, the trustees and auditors confirm the charity remains a going concern with adequate resources to continue operations through at least September 2026.
What the accounts disclose
“The unrestricted free reserves of £909,644 represent 2.7 months’ of 2025 budgeted unrestricted operating expenditure. This is slightly below the IAPB’s policy of 3 months’ of free unrestricted operating expenditure.” — page 8
“the charity has a wholly-owned subsidiary company, IAPB Trading Limited, which has not traded in 2024 or 2023.” — page 5
Structured financials (annual return, FY ending 31/12/2024)
Trustees
- Azra Herceg
- Brandon Ah Tong
- Debra Davis
- Dr Abdulaziz AIRajhi
- Dr Andrew Blakie
- Dr Bruce Spivey
- Dr CAROLINE ANNE HARPER
- Dr CINDY TROMANS
- Dr Caroline Casey
- Dr Chet Raj Pant
- Dr Fatima Kyari
- Dr Geoffrey Wabulembo
- Dr Muhammad Babar Qureshi
- Dr Neeru Gupta
- Dr Nitin Verma
- Dr Rainer Brockhaus
- Dr Rohit Khanna
- Dr Valeria Sanchez Huerta
- Elizabeth Kurian
- Farhana Rehman-Furs
- Gail Grant
- Jacqueline Grove
- Jeffrey Todd
- Jennifer Chen
- Katherine Overbey
- Katie Buckley
- Ryan Toews Afara
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £4.0m | £3.4m |
| 31/12/2023 | £3.1m | £3.4m |
| 31/12/2022 | £3.0m | £3.0m |
| 31/12/2021 | £2.3m | £2.3m |
| 31/12/2020 | £2.2m | £4.2m |
Common questions
Is INTERNATIONAL AGENCY FOR THE PREVENTION OF BLINDNESS financially healthy?
The accounts state that unrestricted free reserves stood at £909,644, representing 2.7 months of budgeted operating expenditure, which is slightly below the charity's own policy target of three months. Despite this slight shortfall, the trustees and auditors confirm the charity remains a going concern with adequate resources to continue operations through at least September 2026. Its FY2024 accounts were audited by Crowe U.K. LLP.